RT Journal Article
SR Electronic
T1 Fulvestrant increases the susceptibility of enzalutamide-resistant prostate cancer cells to NK-mediated lysis
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e007386
DO 10.1136/jitc-2023-007386
VO 11
IS 9
A1 Dahut, Madeline
A1 Fousek, Kristen
A1 Horn, Lucas A
A1 Angstadt, Shantel
A1 Qin, Haiyan
A1 Hamilton, Duane H
A1 Schlom, Jeffrey
A1 Palena, Claudia
YR 2023
UL http://jitc.bmj.com/content/11/9/e007386.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.